An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT05866445
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Registry
-
NCT05866445
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Singapore
- Registry status
- Completed
Technical summary
Registry record NCT05866445. Randomized; triple masking; primary purpose treatment. Start 2023-03-15 (actual); primary completion 2025-04-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control
- Condition
- Hypertension
- Intervention (Device)
- Wearable BP device
- Intervention (Device)
- 24-hour ambulatory blood pressure monitor
- Lead sponsor
- National Heart Centre Singapore
Record details
- Record id
cardio:ct-nct05866445- Content hash
92fe5158e2bdaf5df904d6b4ac6d8d614f9198a8719b7b53713f29fd8ad21e35